$JUNO Juno Therapeutics, Inc. Insider Trading Week 51/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Juno Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Juno Therapeutics, Inc. in week 51/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | C | 0.00 | 75,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Buy | C | 0.00 | 75,000 | 0 | 150,000 | 75 K to 150 K (+100.00 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 457,875 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 3,747,500 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 6,250,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 457,875 | 0 | 11,552,390 | 11.1 M to 11.6 M (+4.13 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 3,747,500 | 0 | 11,094,515 | 7.3 M to 11.1 M (+51.01 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 6,250,000 | 0 | 7,347,015 | 1.1 M to 7.3 M (+569.73 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 68,395 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 1,250,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 2,277,732 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 8,750,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 13,750,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 68,395 | 0 | 1,318,395 | 1.3 M to 1.3 M (+5.47 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 1,250,000 | 0 | 1,250,000 | 0 to 1.3 M |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 2,277,732 | 0 | 25,766,130 | 23.5 M to 25.8 M (+9.70 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 8,750,000 | 0 | 23,488,398 | 14.7 M to 23.5 M (+59.37 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 13,750,000 | 0 | 14,738,398 | 988.4 K to 14.7 M (+1,391.14 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Buy | P | 25.00 | 625,000 | 15,625,000 | 988,398 | 363.4 K to 988.4 K (+171.99 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel and ... | Option Exercise | C | 0.00 | 1,689 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel and ... | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel and ... | Buy | C | 0.00 | 1,689 | 0 | 26,689 | 25 K to 26.7 K (+6.76 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel and ... | Buy | C | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Option Exercise | C | 0.00 | 1,749,999 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Buy | C | 0.00 | 1,749,999 | 0 | 1,749,999 | 0 to 1.7 M |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 457,875 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 3,747,500 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 6,250,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 457,875 | 0 | 11,552,390 | 11.1 M to 11.6 M (+4.13 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 3,747,500 | 0 | 11,094,515 | 7.3 M to 11.1 M (+51.01 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 6,250,000 | 0 | 7,347,015 | 1.1 M to 7.3 M (+569.73 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Barron Hal | Director | Buy | P | 24.00 | 100,000 | 2,400,000 | 100,000 | 0 to 100 K |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Tessier-Lavigne Marc | Director | Option Exercise | C | 0.00 | 175,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Tessier-Lavigne Marc | Director | Buy | C | 0.00 | 175,000 | 0 | 250,000 | 75 K to 250 K (+233.33 %) |